Results 161 to 170 of about 7,522 (217)

An AI-powered diagnostic system for grading and invasion of non-muscle-invasive bladder cancer via TURBT specimens: A multicenter study. [PDF]

iScience
Zhang X, Wang H, Zhou H, Xiao D, Xiong H, Cheng J, He Y, Feng Q, Yang J.   +8 more
europepmc   +1 more source

Therapeutic and prognostic value of repeat transurethral resection for high-grade Ta bladder cancer: a propensity score matching analysis. [PDF]

Am J Cancer Res
Zhang X, Wang L, Sun W, Yang X.
europepmc   +1 more source

A case report of primary mucinous adenocarcinoma of the bladder and literature review. [PDF]

Front Oncol
Li Y, Peng X, Jin S, Wang Q.
europepmc   +1 more source

Correlation Between the Natural Course and Magnetic Resonance Imaging Features of Bacillus Calmette-Guérin-Related Granulomatous Prostatitis in Patients With Bladder Cancer. [PDF]

J Korean Med Sci
Sim KC, Sung DJ, Han NY, Han YE, Park BJ, Kim MJ.   +5 more
europepmc   +1 more source

Economic benefit of photodynamic diagnosis-assisted TURBT

Japanese Journal of Endourology and Robotics
Miyake, Makito, Nishimura, Nobutaka, Fujimoto, Kiyohide   +2 more
openaire   +1 more source

Relook TURBT in superficial bladder cancer: Its importance and its correlation with the tumor ploidy

Urologic Oncology: Seminars and Original Investigations, 2009
To evaluate various prognostic factor predictors of residual growth in Relook transurethral resection of bladder tumor (TURBT) in superficial bladder cancer.
Sameer Trivedi, Pratap B Singh, Suren K Das   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light?

Urologic Oncology: Seminars and Original Investigations, 2023
To evaluate whether a restaging transurethral resection of bladder tumor (TURBT) is necessary in high-risk nonmuscle invasive bladder cancer (NMIBC) if the initial TURBT was performed using blue light (BL) technology.Using the multi-institutional Cysview registry between 2014 and 2021, all consecutive adult patients with known NMIBC (Ta and T1 disease)
Muhannad Alsyouf, Seyedeh-Sanam Ladi-Seyedian, Badrinath Konety, Kamal Pohar, Jeffrey M. Holzbeierlein, Max Kates, Brian Willard, Jennifer M. Taylor, Joseph C. Liao, Hristos Z. Kaimakliotis, Sima P. Porten, Gary D. Steinberg, Mark D. Tyson, Yair Lotan, Siamak Daneshmand   +14 more
openaire   +2 more sources